Chimeric antigen receptor T-cell (CAR-T) therapy provided to Medicare Advantage (MA) beneficiaries will be paid for by traditional Medicare for calendar years 2019 and 2020.
This week’s Medicare updates include the October edition of the Medicare Quarterly Compliance Newsletter, a pair of requests for information on potential usage of artificial intelligence to prevent fraud, Medicare Advantage billing instructions for CAR-T therapy, and more!
A federal judge rejected CMS’ motion to reconsider or issue a stay on her September order to vacate cuts to reimbursement to grandfathered off-campus provider-based departments.
This week’s Medicare updates includes 2020 payment rates for the Medicare Diabetes Prevention Program, updates to the OIG work plan, guidance on coding for encounters related to vaping illnesses, and more!
Q: Is there a recommended practice for how modifiers should be included in the chargemaster? Is it preferred to add them as a separate field or included in the HCPCS field?
